FDA grants accelerated approval to Elamipretide

Hims House

@himshouse

·Follow

🚨 BREAKING: FDA GRANTS ACCELERATED APPROVAL TO ELAMIPRETIDE, A PEPTIDE FOR TREATING BARTH SYNDROME - First treatment for Barth Syndrome - Barth is a rare, life-threatening mitochondrial disease - Most importantly, signals FDA's newfound openness to peptides $HIMS $LLY $NVO